Patents for A61P 35 - Antineoplastic agents (221,099)
08/2007
08/22/2007CN101020703A Total alkaloid of pink plumepoppy herb
08/22/2007CN101020700A Ruthenium porphyrin complex and its prepn process and application as photosensitizer for photodynamic therapy
08/22/2007CN101020699A Metal complex with liriodenine as ligand and its synthesis process and use
08/22/2007CN101020689A 1-(3-indolyl)-6,7-methylene dioxy-1,2,3,4-tetrahydro isoquinoline derivative and its prepn and use
08/22/2007CN101020688A 1-(3-indolyl)-1,2,3,4-tetrahydro-beta-carboline derivative and its prepn and use
08/22/2007CN101020654A Antitumor compound and its prepn process
08/22/2007CN101020637A Prepn process and application of resemary acid
08/22/2007CN101020062A Hydrophilic polyglycol supported ursolic acid medicines and their prepn process
08/22/2007CN101020059A Medicine composition containing docetaxel matter and its prepn process
08/22/2007CN101020057A Composition for treating solid tumor
08/22/2007CN101020044A Regulating and controlling effect of thymine DNA glycosylase on signal transducing path
08/22/2007CN101020035A Externally applied Chinese medicine for treating cancer
08/22/2007CN101020026A Honeyed Guiqi ointment for enhancing body's resistance and its prepn
08/22/2007CN101020002A Compound Chinese medicine prepn for assisting tumor radiotherapy and its prepn
08/22/2007CN101019968A Oral Chinese medicine composition for treating malignant tumor
08/22/2007CN101019923A Anticancer medicine and its prepn
08/22/2007CN101019903A Application of asafetida and volatile asafetida oil in preparing anticarcinogen
08/22/2007CN101019902A Slow releasing micro pill prepn of loosestrife extract and its prepn process
08/22/2007CN101019899A Buccal tablet of aweto or aweto extract
08/22/2007CN101019897A Antitumor medicine composition and its prepn
08/22/2007CN101019893A Process of enriching effective antitumor part of periplaneta americana with polyamide
08/22/2007CN101019891A Toad skin total alkaloid and its prepn, analysis and prepn process
08/22/2007CN101019887A Externally applied medicine for treating cancer and its prepn
08/22/2007CN101019880A Nanometer liver targeting floxuridine powder for injection and its prepn
08/22/2007CN101019857A Injectable micelle prepn containing garcinolic acid and its prepn process
08/22/2007CN101019856A Allonic acid compound possessing antitumor activity and its prepn process, prepn and use
08/22/2007CN101019835A Lignum sappan and its prepn process and application
08/22/2007CN101019834A Prepn of 7-ethyl-10-hydroxycamptothecine liposome for injection
08/22/2007CN101019832A Docetaxel fat milk and its freeze dried prepn and their prepn process
08/22/2007CN101019831A Slow releasing anticancer prepn containing vasoinhibitor
08/22/2007CN101019830A Anticancer composition containing phosphoinositide-3-kinase inhibitor and topomerase inhibitor
08/22/2007CN101019829A Slow releasing anticancer prepn containing vasoinhibitor
08/22/2007CN101019828A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and hormone medicine
08/22/2007CN101019827A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and alkylating agent
08/22/2007CN101019824A Oral medicine composition containing salvianolic acid and its prepn
08/21/2007US7259270 Supermolecular carboplatin derivatives, their preparation and pharmaceutical composition containing them as active ingredient and applications of the compositions
08/21/2007US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule.
08/21/2007US7259232 Preferred segments of neural thread protein
08/21/2007US7259188 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators
08/21/2007US7259187 Tropolone derivatives
08/21/2007US7259179 Kinase inhibitors
08/21/2007US7259171 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
08/21/2007US7259164 Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
08/21/2007US7259162 Benzazole derivatives and their use as JNK modulators
08/21/2007US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders
08/21/2007US7259154 Pyrrolopyrimidines
08/21/2007US7259148 Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid
08/21/2007US7259137 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
08/21/2007US7259012 Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cells
08/21/2007US7259009 Self-rearranging DNA vectors
08/21/2007US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer
08/21/2007US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed
08/21/2007CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use
08/21/2007CA2285054C Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
08/21/2007CA2196419C Improvements in or relating to binding proteins for recognition of dna
08/21/2007CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
08/16/2007WO2007092436A2 Compounds for treating inflammatory disorders, demyelinating disorders and cancers
08/16/2007WO2007092403A1 N-phenylbenzotriazolyl c-kit inhibitors
08/16/2007WO2007092213A2 Inhibitors of e1 activating enzyme
08/16/2007WO2007092178A1 Hydrate forms of amg706
08/16/2007WO2007091744A1 Pharmaceutical composition containing an extract of ulmus davidiana planch for the prevention and treatment of glioma
08/16/2007WO2007091736A1 Novel coumarin derivative having antitumor activity
08/16/2007WO2007091703A1 N-hydroxyacrylamide compounds
08/16/2007WO2007091681A1 Radiotherapy enhancing agent in radiotherapy for tumor
08/16/2007WO2007091661A1 Sugar chain-modified liposome suitable for molecular imaging and utilization and production of the same
08/16/2007WO2007091622A1 Anti-cancer pharmaceutical composition
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate
08/16/2007WO2007091557A1 Pharmaceutical composition for treatment or prevention of liver cancer
08/16/2007WO2007091328A1 Method for treatment of lung cancer
08/16/2007WO2007091313A1 Cytokine production inhibitor and heterocyclic phenoxy derivative
08/16/2007WO2007091241A1 Treatment of ovarian cancer
08/16/2007WO2007090897A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
08/16/2007WO2007090807A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
08/16/2007WO2007090794A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
08/16/2007WO2007090670A1 Treatment of metastatic breast cancer
08/16/2007WO2007090494A1 Amino indazole derivatives
08/16/2007WO2007090493A1 Indazole heteroaryl derivatives
08/16/2007WO2007090294A1 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment
08/16/2007WO2007076460A3 Substituted thiazole ureas useful as inhibitors of protein kinases
08/16/2007WO2007076086A3 Tricyclic spiro compounds useful as transforming growth factor modulators
08/16/2007WO2007075825A3 Lipophilic anticancer drug compounds
08/16/2007WO2007071442A3 Inhibitors of ccr9 activity
08/16/2007WO2007067506A3 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
08/16/2007WO2007064719A3 Formulations of quinolinones
08/16/2007WO2007061882A3 Pyrrolotriazine kinase inhibitors
08/16/2007WO2007019573A3 Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
08/16/2007WO2007014671A3 Combinations containing ikk-beta inhibitors
08/16/2007WO2007009191A8 Method for treating cancer
08/16/2007WO2007007919A3 Heterocyclic janus kinase 3 inhibitors
08/16/2007WO2006115509A3 Small molecule immunopotentiators and assays for their detection
08/16/2007WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
08/16/2007WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007WO2003031404A3 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
08/16/2007WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
08/16/2007US20070191458 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions
08/16/2007US20070191392 Dipeptide nitrile cathespin k inhibitors
08/16/2007US20070191388 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, antiarthritic, anticarcinogenic, antitumor, antidiabetic; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma
08/16/2007US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin
08/16/2007US20070191372 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
08/16/2007US20070191360 antitumor agents; viricides